No.

PRODUCTS

CAS No.

INDICATIONS

Remark

1

Upadacitinib
(Novel Polymorph)

1310726-60-3

Immune system

DMF*

2

Baricitinib

1187594-09-7

Immune system

DMF*

3

Tofacitinib Citrate

540737-29-9

Rheumatoid arthritis

DMF

4

Deucravacitinib
(BMS-986165)

1609392-27-9

Lupus-like disease/TYK2

TDP

5

Apremilast

608141-41-9

Psoriasis

DMF

6

Upadacitinib

1310726-60-3

Immune system/JAK1

DMF